Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 24, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 29, 2026
OfficerIndirect holdingGift / transfer
Context
Classification
gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-405402
Filed / recorded
Sep 29, 2026, 12:30 AM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CORCEPT THERAPEUTICS INC
Issuer CIK
1088856
Ticker
CORT
Reporting person
Gary Charles Robb
Relationship
Officer
Officer title
Chief Business Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 24, 2026
Transaction code
G
Shares / units
5,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
20,571
Ownership form
Indirect — Custodial Account for Child
Amendment
No
Footnotes from the filing
These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.